Nordhealth Past Earnings Performance

Past criteria checks 0/6

Nordhealth's earnings have been declining at an average annual rate of -51.6%, while the Healthcare Services industry saw earnings growing at 6.7% annually. Revenues have been growing at an average rate of 32.1% per year.

Key information

-51.6%

Earnings growth rate

-40.9%

EPS growth rate

Healthcare Services Industry Growth2.9%
Revenue growth rate32.1%
Return on equity-13.5%
Net Margin-30.2%
Next Earnings Update12 Apr 2024

Recent past performance updates

Recent updates

What You Can Learn From Nordhealth AS' (OB:NORDH) P/S

Feb 23
What You Can Learn From Nordhealth AS' (OB:NORDH) P/S

Nordhealth (OB:NORDH) Is In A Good Position To Deliver On Growth Plans

Jan 03
Nordhealth (OB:NORDH) Is In A Good Position To Deliver On Growth Plans

Getting In Cheap On Nordhealth AS (OB:NORDH) Might Be Difficult

May 12
Getting In Cheap On Nordhealth AS (OB:NORDH) Might Be Difficult

Estimating The Intrinsic Value Of Nordhealth AS (OB:NORDH)

Jan 25
Estimating The Intrinsic Value Of Nordhealth AS (OB:NORDH)

Revenue & Expenses Breakdown
Beta

How Nordhealth makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OB:NORDH Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2337-1130
30 Sep 2335-1230
30 Jun 2334-1430
31 Mar 2333-1530
31 Dec 2231-1430
30 Sep 2229-1210
30 Jun 2227-1020
31 Mar 2224-810
31 Dec 2120-510
30 Sep 2118-2-10
30 Jun 21150-20
31 Mar 2113200
31 Dec 2013200
31 Dec 198-100
31 Dec 185-100

Quality Earnings: NORDH is currently unprofitable.

Growing Profit Margin: NORDH is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: NORDH is unprofitable, and losses have increased over the past 5 years at a rate of 51.6% per year.

Accelerating Growth: Unable to compare NORDH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NORDH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (8.6%).


Return on Equity

High ROE: NORDH has a negative Return on Equity (-13.45%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.